Trial
NCT01865084
A Study of Tadalafil for Duchenne Muscular Dystrophy
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Muscular Dystrophy, Duchenne
Intervention
Tadalafil
Why stopped
The study is being terminated for lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-09